Advertisement

Legal & Regulatory Issues

The U.S. Food and Drug Administration will review its decision to approve the Menaflex knee-surgery device after several scientists and FDA managers raised objections over the approval process, according to an article in The Wall Street Journal.  

In a letter to Assistant Attorney General for Antitrust Christine Varney, the American Hospital Association executive vice president Rick Pollack encouraged the Antitrust Division of the U.S. Department of Justice to take a closer look at health insurance plan consolidation,…

A recent report from the Institute of Medicine recommends several actions to improve disclosure of financial ties between the medical community and industry, limit company payments and gifts and remove industry influence from medical education and the development of practice…

Advertisement
Advertisement